STTK SHATTUCK LABS INC
2026Q1 · CUSIP 82024L103 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
83
Δ holders QoQ
+18
Breadth percentile
Top 17%
Whale holders
47
Δ whales
+9
Inst. holding value
$614M
New positions
24
Closed positions
6
Price momentum (1Q)
+49.2%
Put / Call
0/0
Breadth history (34 quarters)
Past Lit Events & Aftermath 1 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 17% | — | — |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
0
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.56
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-78.3%
Net margin
—
ROE
-52.0%
Debt ratio
6.2%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.